Pharmacy benefit costs now account for 25% of healthcare spending and are projected to increase by 12% nationally through 2027. Meanwhile, the public sector in the Northeast is facing significantly higher trends of 18% to 20%. These unprecedented numbers are being largely driven by the skyrocketing use of GLP-1s, oncology medications, and increased usage of … Continue reading Why Would Employers “Roll the Dice” on Their Rx Benefit Program?